Eclat Pharma And Aerosols Pvt Ltd - Company Profile

It is a healthcare private limited company based in Mumbai, Maharashtra, India, established in 1991.
1991 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Eclat Pharma And Aerosols Pvt Ltd

Eclat Pharma And Aerosols Pvt Ltd, a active private limited company, was established on 26 June 1991 in Mumbai, Maharashtra, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24239MH1991PTC062241. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.62 M.

It upholds a compliant status. Employing 37 professional, Its leadership includes Abhishek Dhruva Pradhan (Director), Chetna Dhruva Pradhan (Director), Urvashi Dhruva Pradhan (Director). Past directors included Sharad Ramchandra Kalburge, Urvashi Dhruva Pradhan, Dhruva Manbahadur Pradhan. It holds ₹1.80 Cr open charges and ₹1.92 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B 702/703, Siddhi Avenue Chs Ltd., Chikuwadi, Shimpoli Road, Borivali (West),, Mumbai, Maharashtra, 400092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH1991PTC062241

  • Registration Number

    062241

  • Incorporation Date

    26 June 1991

  • Authorized Capital

    ₹2.00 M

  • Paid-Up Capital

    ₹0.62 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 M
  • Paid Up Capital ₹ 0.62 M
  • Company Age 34 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1.80 Cr
  • Satisfied Charges ₹ 1.92 Cr
  • Revenue Growth **** -17.08%
  • Profit Growth **** -46.04%
  • Ebitda **** 19.72%
  • Net Worth 6.03%
  • Total Assets -8.97%
Company report

Eclat Pharma And Aerosols Pvt Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Eclat Pharma And Aerosols Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Eclat Pharma And Aerosols Pvt Ltd?
Current Directors
Name Designation Appointment Date Status
Abhishek Dhruva Pradhan Director 23 May 2018 Current
Chetna Dhruva Pradhan Director 23 May 2018 Current
Urvashi Dhruva Pradhan Director 23 Nov 2021 Current
Dhruva Manbahadur Pradhan Director 23 Nov 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 02 Feb 2009 Past
Pramod Abcsdd Director 15 Mar 2019 Past
Pramod Abcsdd Director 15 Mar 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eclat Pharma And Aerosols.

Eclat Pharma And Aerosols Pvt Ltd, for the financial year ended 2024, experienced significant reduction in revenue, with a 17.08% decrease. The company also saw a substantial fall in profitability, with a 46.04% decrease in profit. The company's net worth moved up by a moderate rise of 6.03%.

Eclat Pharma And Aerosols revenue growth over time
Eclat Pharma And Aerosols profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -17.08%
*******
*******
*******
*******
Revenue from Operations
*******
 -17.08%
*******
*******
*******
*******
Total Assets
*******
 -8.97%
*******
*******
*******
*******
Profit or Loss
*******
 -46.04%
*******
*******
*******
*******
Net Worth
*******
 6.03%
*******
*******
*******
*******
EBITDA
*******
 19.72%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eclat Pharma And Aerosols?

Unlock access to Eclat Pharma And Aerosols's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹18,000,000.00

Satisfied Charges

₹19,221,885.00

Charges Breakdown by Lending Institutions
  • Others : 1.80 Cr
Latest Charge Details
Date Lender Amount Status
21 Mar 2013 Others ₹1.80 Cr Open
23 Mar 2019 Others ₹0.52 M Satisfied
04 Jul 2014 Vasai Janata Sahkari Bank Ltd ₹0.80 M Satisfied
07 Apr 2013 Vasai Janata Sahakari Bank Limited ₹6.30 M Satisfied
28 Nov 2008 Vasai Janata Sahakari Bank Limited ₹2.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Eclat Pharma And Aerosols?

Eclat Pharma And Aerosols has a workforce of 37 employees as of Oct 11, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eclat Pharma And Aerosols, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eclat Pharma And Aerosols's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eclat Pharma And Aerosols
Recent Activity within the Organization
  • Charges

    Progress on A charge with Others of Rs. 18.00 M registered on 21 Mar 2013 with Charge ID 10453951 was modified on 30 Apr 2025. was documented.

  • Annual General Meeting

    Progress on Eclat Pharma And Aerosols Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Eclat Pharma And Aerosols Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.

  • Charges

    Progress on A charge registered on 23 Mar 2019 via Charge ID 100274717 with Others was fully satisfied on 22 Aug 2023. was documented.

  • Director Appointment

    The activity Urvashi Dhruva Pradhan was appointed as a Director was appointed as a Director on 23 Nov 2021 & has been associated with this company since 4 years 3 months . was completed.

  • Director Appointment

    Progress on Dhruva Manbahadur Pradhan was appointed as a Director was appointed as a Director on 23 Nov 2021 & has been associated with this company since 4 years 3 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Eclat Pharma And Aerosols Pvt Ltd?

The CIN of Eclat Pharma And Aerosols Pvt Ltd is U24239MH1991PTC062241.

Where is Eclat Pharma And Aerosols Pvt Ltd headquartered?

Eclat Pharma And Aerosols Pvt Ltd is headquartered at B 702/703, Siddhi Avenue Chs Ltd., Chikuwadi, Shimpoli Road, Borivali (West),, Mumbai, Maharashtra, 400092.

When was Eclat Pharma And Aerosols Pvt Ltd incorporated?

Eclat Pharma And Aerosols Pvt Ltd was incorporated on 26 June 1991.

Who are the current directors of Eclat Pharma And Aerosols Pvt Ltd?

The current directors of Eclat Pharma And Aerosols Pvt Ltd are

What is the primary industry of Eclat Pharma And Aerosols Pvt Ltd?

The primary industry of Eclat Pharma And Aerosols Pvt Ltd is Manufacturing.

Is Eclat Pharma And Aerosols Pvt Ltd a listed company?

Eclat Pharma And Aerosols Pvt Ltd is unlisted.

What is the capital structure of Eclat Pharma And Aerosols Pvt Ltd?

The authorized capital of Eclat Pharma And Aerosols Pvt Ltd is ₹2.00 M, and the paid-up capital is ₹0.62 M.

What is the compliance status of Eclat Pharma And Aerosols Pvt Ltd?

The compliance status of Eclat Pharma And Aerosols Pvt Ltd is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available